obesity

News

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, who will take on the dual roles of president

News

Lilly ups spend on diabetes, obesity drug production to $9bn

Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indian

News

Click buys Better assets to speed its digital obesity drive

Click Therapeutics has snapped up the assets of troubled digital health company Better Therapeutics, including its FDA-approved prescription digital therapeutic (PDT) for

News

Roche trumpets potential ‘best-in-class’ obesity drug

Roche has reported early clinical data with its candidate obesity therapy CT-388, bought as part of its $3.1 billion takeover of Carmot Therapeutics that was announced las

News

Semaglutide heart benefits may go beyond weight loss

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss.

News